Skip to main content

Table 1 Subject characteristics

From: Role of p73 in Alzheimer disease: lack of association in mouse models or in human cohorts

Cohort

AD cases

Controls (N)

 

N

Age at onset

APOEε2/ε3/ε4

N

Age at exam

APOEε2/ε3/ε4

  

(mean ± SD)

(allele %)

 

(mean ± SD)

(allele %)

ACT

566

83.90 (4.8)

0.05 / 0.69 / 0.26

1696

81.08 (6.0)

0.08 / 0.81 /0.11

ADC1

1566

72.47 (7.1)

0.03 / 0.55 / 0.42

515

75.00 (8.0)

0.08 / 0.76 / 0.16

ADC2

738

73.19 (7.1)

0.03 / 0.57 / 0.39

160

75.68 (7.9)

0.09 / 0.75 / 0.16

ADNI

268

75.30 (7.2)

0.03 / 0.55 / 0.42

173

78.6 (5.5)

0.08 / 0.79 / 0.14

GenADA

669

74.59 (6.2)

0.04 / 0.58 / 0.38

713

74.21 (7.0)

0.08 / 0.79 / 0.13

MIAMI

1186

74.06 (7.8)

0.03 / 0.61 / 0.36

1135

74.00 (8.3)

0.08 / 0.80 / 0.12

MIRAGE

509

71.16 (6.5)

0.04 / 0.60 / 0.36

753

72.04 (7.2)

0.06 / 0.72 / 0.23

NIA-LOAD

1811

73.57 (6.7)

0.02 / 0.51 / 0.46

1575

73.99 (8.5)

0.07 / 0.73 / 0.20

OHSU

132

86.10 (5.5)

0.07 / 0.70 / 0.23

153

83.86 (7.6)

0.10 / 0.82 / 0.08

TGEN

864

74.91 (7.2)

0.04 / 0.57 / 0.40

493

80.19 (8.7)

0.10 / 0.79 / 0.11

TOTAL

8309

--

--

7366

--

--